LilieLLinMD

Radiation Oncology • Houston, TX

Professor, Radiation Oncology, MD Anderson Cancer Center

Join to view full profile

Dr. Lin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lin's full profile

Already have an account?

Office
1515 Holcombe Blvd
Houston, TX 77030
Phone+1 713-792-6161

Fax+1 215-349-5923

Education & Training

Washington University/B-JH/SLCH ConsortiumResidency, Radiation Oncology, 2002 - 2006
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2001 - 2002
Washington University in St. Louis School of MedicineClass of 2001

Certifications & Licensure

FL State Medical License 2021 - Present
TX State Medical License 2017 - 2025
OK State Medical License 2020 - 2021
PA State Medical License 2006 - 2018
NJ State Medical License 2006 - 2017
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer Start of enrollment: 2005 Jan 01
Completed
Not Applicable
Bowman-Birk Inhibitor Concentrate in Healthy Men Start of enrollment: 2007 Jun 01
Completed
Phase 1
Fluorine F 18 EF5 PET/CT Imaging in Patients With Locally Advanced or Recurrent/Metastatic Cervical Cancer Start of enrollment: 2008 May 01
Terminated
Not Applicable
Yoga for Breast Cancer Start of enrollment: 2013 Mar 01
Completed
Not Applicable
F18 EF5 PET/CT Imaging in Patients With Brain Metastases From Breast Cancer Start of enrollment: 2011 Mar 01
Completed
Not Applicable
Suitability of DCE-MRI for Detection of Vascular Changes After VBT Start of enrollment: 2013 Oct 01
Completed
Not Applicable
[18F] Flourothymidine (FLT) PET/CT Imaging for Gynecologic Cancers Start of enrollment: 2014 Feb 01
Completed
Assessing the Impact of Electronic Capture of Patient Reported Outcomes in Radiation Oncology Start of enrollment: 2016 Apr 01
Completed
Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers Start of enrollment: 2018 Jul 18
Completed
Phase 1
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF Start of enrollment: 2018 Dec 18
Recruiting
Phase 1
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers Start of enrollment: 2019 Sep 26
Recruiting
Phase 1
Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery Start of enrollment: 2020 Aug 07
Recruiting
Phase 1
A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer Start of enrollment: 2023 Feb 27
Suspended
Phase 2
Roles: Principal Investigator, Contact
Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors Start of enrollment: 2020 Jan 09
Active, not recruiting
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

[F]Fluorthanatrace PET in Ovarian Cancer: Comparison with [F]FDG PET, Lesion Location, Tumor Grade, and Breast Cancer Gene Mutation Status.
Joanna K Weeks, Austin R Pantel, Sarah B Gitto, Fang Liu, Erin K Schubert
Journal of Nuclear Medicine. 2025-01-03
Human Papilloma Virus Circulating Cell-Free DNA Kinetics in Cervical Cancer Patients Undergoing Definitive Chemoradiation.
Aaron Seo, Weihong Xiao, Olsi Gjyshi, Kyoko Yoshida-Court, Peng Wei
Clinical Cancer Research. 2024-12-16
Excess Mortality in Persons with Concurrent HIV and Cancer Diagnoses: A Retrospective Cohort Study.
Kamaria L Lee, Varada Sarovar, Jennifer O Lam, Wendy A Leyden, Stacey E Alexeeff
Cancer Epidemiology, Biomarkers & Prevention. 2024-12-02

Press Mentions

MD Anderson Research Highlights Special Edition: ASTRO 2024September 27th, 2024
It Takes a Team to Get Through Primary Peritoneal CancerApril 23rd, 2019